Translator Disclaimer
6 October 2016 State-of-the-Art Advances in Radiation Biodosimetry for Mass Casualty Events Involving Radiation Exposure
Author Affiliations +
Abstract

With the possibility of large-scale terrorist attacks around the world, the need for modeling and development of new medical countermeasures for potential future chemical, biological, radiological and nuclear (CBRN) has been well established. Project Bioshield, initiated in 2004, provided a framework to develop and expedite research in the field of CBRN exposures. To respond to large-scale population exposures from a nuclear event or radiation dispersal device (RDD), new methods for determining received dose using biological modeling became necessary. The field of biodosimetry has advanced significantly beyond this original initiative, with expansion into the fields of genomics, proteomics, metabolomics and transcriptomics. Studies are ongoing to evaluate the use of lymphocyte kinetics for dose assessment, as well as the development of field-deployable EPR technology. In addition, expansion of traditional cytogenetic assessment methods through the use of automated platforms and the development of laboratory surge capacity networks have helped to advance our biodefense preparedness. In this review of the latest advances in the field of biodosimetry we evaluate our progress and identify areas that still need to be addressed to achieve true field-deployment readiness.

©2016 by Radiation Research Society.
Mary Sproull and Kevin Camphausen "State-of-the-Art Advances in Radiation Biodosimetry for Mass Casualty Events Involving Radiation Exposure," Radiation Research 186(5), 423-435, (6 October 2016). https://doi.org/10.1667/RR14452.1
Received: 7 March 2016; Accepted: 1 July 2016; Published: 6 October 2016
JOURNAL ARTICLE
13 PAGES


SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top